State of Wyoming’s Teva Pharmaceuticals TEVA Stock Holding History

State of Wyoming’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$183K	Sell	5,400 -2,966	-35%	-$98.8K	0.02%	1072
2026 Q1	$252K	Sell	8,366 -16,142	-66%	-$519K	0.03%	790
2025 Q4	$765K	Buy	24,508 +1,943	+9%	+$47.9K	0.08%	162
2025 Q3	$456K	Buy	22,565 +4,729	+27%	+$83.1K	0.05%	363
2025 Q2	$299K	Buy	+17,836	New	+$288K	0.04%	653
2022 Q2	–	Sell	-2,578	Closed	-$24K	–	2131
2022 Q1	$24K	Buy	2,578 +220	+9%	+$1.84K	0.01%	1389
2021 Q4	$19K	Buy	2,358 +453	+24%	+$4.09K	0.01%	1486
2021 Q3	$19K	Sell	1,905 -891	-32%	-$8.34K	0.01%	947
2021 Q2	$28K	Buy	2,796 +1,655	+145%	+$17.5K	0.02%	870
2021 Q1	$13K	Buy	+1,141	New	+$13.1K	0.02%	366

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

State of Wyoming's TEVA Position: Q2 2026 in Review

State of Wyoming reduced its Teva Pharmaceuticals (TEVA) stake by 35% in Q2 2026, selling an estimated $98.8K and leaving 5,400 shares worth $183K. The position accounts for 0.02% of the portfolio, ranked #1072.

State of Wyoming first reported a position in TEVA in Q1 2021 and has held it in 10 quarters since. The position peaked at $765K in Q4 2025. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

State of Wyoming held 5,400 shares of Teva Pharmaceuticals worth $183K as of Q2 2026.
State of Wyoming sold 2,966 Teva Pharmaceuticals shares in Q2 2026, an estimated $98.8K.
Teva Pharmaceuticals made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #1072 holding.
State of Wyoming first reported a position in Teva Pharmaceuticals in Q1 2021 and has held it in 10 quarters since.
State of Wyoming's Teva Pharmaceuticals position peaked at $765K in Q4 2025.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.